40 related articles for article (PubMed ID: 16466920)
1. New derivatives of silybin and 2,3-dehydrosilybin and their cytotoxic and P-glycoprotein modulatory activity.
Dzubák P; Hajdúch M; Gazák R; Svobodová A; Psotová J; Walterová D; Sedmera P; Kren V
Bioorg Med Chem; 2006 Jun; 14(11):3793-810. PubMed ID: 16466920
[TBL] [Abstract][Full Text] [Related]
2. Enhanced bioactivity of silybin B methylation products.
Sy-Cordero AA; Graf TN; Runyon SP; Wani MC; Kroll DJ; Agarwal R; Brantley SJ; Paine MF; Polyak SJ; Oberlies NH
Bioorg Med Chem; 2013 Feb; 21(3):742-7. PubMed ID: 23260576
[TBL] [Abstract][Full Text] [Related]
3. 7-
Romanucci V; Pagano R; Kandhari K; Zarrelli A; Petrone M; Agarwal C; Agarwal R; Di Fabio G
Antioxidants (Basel); 2024 Mar; 13(4):. PubMed ID: 38671866
[TBL] [Abstract][Full Text] [Related]
4. Perplexing Polyphenolics: The Isolations, Syntheses, Reappraisals, and Bioactivities of Flavonoids, Isoflavonoids, and Neoflavonoids from 2016 to 2022.
Umer SM; Shamim S; Khan KM; Saleem RSZ
Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983891
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of novel silibinin and 2,3-dehydrosilybin derivatives with carbamate groups.
Wu Q; Zeng J; Dong J
Med Chem Res; 2022; 31(4):533-544. PubMed ID: 35194363
[TBL] [Abstract][Full Text] [Related]
6. 2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines.
Kotulova J; Lonova K; Kubickova A; Vrbkova J; Kourilova P; Hajduch M; Dzubak P
Int J Mol Med; 2022 Mar; 49(3):. PubMed ID: 35039871
[TBL] [Abstract][Full Text] [Related]
7. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.
Koltai T; Fliegel L
J Evid Based Integr Med; 2022; 27():2515690X211068826. PubMed ID: 35018864
[TBL] [Abstract][Full Text] [Related]
8. Novel molecules as the emerging trends in cancer treatment: an update.
Sekar P; Ravitchandirane R; Khanam S; Muniraj N; Cassinadane AV
Med Oncol; 2022 Jan; 39(2):20. PubMed ID: 34982273
[TBL] [Abstract][Full Text] [Related]
9. Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners.
Křen V
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360650
[TBL] [Abstract][Full Text] [Related]
10. Lung Cancer Management with Silibinin: A Historical and Translational Perspective.
Verdura S; Cuyàs E; Ruiz-Torres V; Micol V; Joven J; Bosch-Barrera J; Menendez JA
Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34208282
[TBL] [Abstract][Full Text] [Related]
11. Simple and Rapid HPLC Separation and Quantification of Flavonoid, Flavonolignans, and 2,3-Dehydroflavonolignans in Silymarin.
Petrásková L; Káňová K; Biedermann D; Křen V; Valentová K
Foods; 2020 Jan; 9(2):. PubMed ID: 31973217
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Silymarin Flavonolignans and Their Sulfated Conjugates on Platelet Aggregation and Blood Vessels Ex Vivo.
Pourová J; Applová L; Macáková K; Vopršalová M; Migkos T; Bentanachs R; Biedermann D; Petrásková L; Tvrdý V; Hrubša M; Karlíčková J; Křen V; Valentová K; Mladěnka P
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31554252
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant, Anti-Inflammatory, and Multidrug Resistance Modulation Activity of Silychristin Derivatives.
Viktorová J; Dobiasová S; Řehořová K; Biedermann D; Káňová K; Šeborová K; Václavíková R; Valentová K; Ruml T; Křen V; Macek T
Antioxidants (Basel); 2019 Aug; 8(8):. PubMed ID: 31416138
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Retinoyl-Flavonolignan Hybrids and Their Antioxidant Properties.
Chambers CS; Biedermann D; Valentová K; Petrásková L; Viktorová J; Kuzma M; Křen V
Antioxidants (Basel); 2019 Jul; 8(7):. PubMed ID: 31340489
[TBL] [Abstract][Full Text] [Related]
15.
Vue B; Zhang S; Vignau A; Chen G; Zhang X; Diaz W; Zhang Q; Zheng S; Wang G; Chen QH
Molecules; 2018 Nov; 23(12):. PubMed ID: 30501133
[TBL] [Abstract][Full Text] [Related]
16. Sulfated Metabolites of Flavonolignans and 2,3-Dehydroflavonolignans: Preparation and Properties.
Valentová K; Purchartová K; Rydlová L; Roubalová L; Biedermann D; Petrásková L; Křenková A; Pelantová H; Holečková-Moravcová V; Tesařová E; Cvačka J; Vrba J; Ulrichová J; Křen V
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096957
[TBL] [Abstract][Full Text] [Related]
17. 5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.
Vue B; Zhang X; Lee T; Nair N; Zhang S; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2017 Sep; 25(17):4845-4854. PubMed ID: 28756013
[TBL] [Abstract][Full Text] [Related]
18. Cancer chemoprevention through dietary flavonoids: what's limiting?
Amawi H; Ashby CR; Tiwari AK
Chin J Cancer; 2017 Jun; 36(1):50. PubMed ID: 28629389
[TBL] [Abstract][Full Text] [Related]
19. Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H:quinone oxidoreductase 1 in Hepa1c1c7 cells.
Roubalová L; Dinkova-Kostova AT; Biedermann D; Křen V; Ulrichová J; Vrba J
Fitoterapia; 2017 Jun; 119():115-120. PubMed ID: 28450126
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
